Medi-chord Liquid
NDC Package 64578-0060-1
Package Information
Medi-chord (homeopathic liquid) liquids is classified as a
- allergens - [cs]
- allergens - [cs]
- amphenicol-class antibacterial - [epc] (established pharmacologic class)
- amphenicols - [ext]
- anti-inflammatory agents administered via oral route. This formulation utilizes a liquid delivery system. Marketed by Energetix Corporation, this product is identified by NDC 64578-0060.
Identification & Billing
Clinical Specifications
- ACETIC ACID 18 [hp_X]/59.1mL
- ASPIRIN 18 [hp_X]/59.1mL
- CORTICOTROPIN HUMAN 18 [hp_X]/59.1mL
- ALUMINUM 18 [hp_X]/59.1mL
- ATROPA BELLADONNA 12 [hp_X]/59.1mL
- BENZENE 12 [hp_X]/59.1mL
- CHLORAMPHENICOL 18 [hp_X]/59.1mL
- CHLORPROMAZINE 18 [hp_X]/59.1mL
- CORTISONE ACETATE 18 [hp_X]/59.1mL
- ESTRONE 18 [hp_X]/59.1mL
- SUS SCROFA ADRENAL GLAND 9 [hp_X]/59.1mL
- GLYCYRRHIZA GLABRA 4 [hp_X]/59.1mL
- PORK LIVER 9 [hp_X]/59.1mL
- POTASSIUM IODIDE 12 [hp_X]/59.1mL
- ARCTIUM LAPPA ROOT 4 [hp_X]/59.1mL
- LYCOPODIUM CLAVATUM SPORE 12 [hp_X]/59.1mL
- NITRIC ACID 12 [hp_X]/59.1mL
- STRYCHNOS NUX-VOMICA SEED 12 [hp_X]/59.1mL
- KEROSENE 18 [hp_X]/59.1mL
- PHENACETIN 18 [hp_X]/59.1mL
- PHOSPHORIC ACID 12 [hp_X]/59.1mL
- PHYTOLACCA AMERICANA ROOT 4 [hp_X]/59.1mL
- LEAD 15 [hp_X]/59.1mL
- FRANGULA PURSHIANA BARK 4 [hp_X]/59.1mL
- PHENYL SALICYLATE 18 [hp_X]/59.1mL
- SARSAPARILLA 4 [hp_X]/59.1mL
- THYROID, UNSPECIFIED 9 [hp_X]/59.1mL
- TRIFOLIUM PRATENSE FLOWER 4 [hp_X]/59.1mL
- ELYMUS REPENS ROOT 4 [hp_X]/59.1mL
- Allergens - [CS]
- Allergens - [CS]
- Amphenicol-class Antibacterial - [EPC] (Established Pharmacologic Class)
- Amphenicols - [EXT]
- Anti-Inflammatory Agents, Non-Steroidal - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Corticosteroid Hormone Receptor Agonists - [MoA] (Mechanism of Action)
- Corticosteroid - [EPC] (Established Pharmacologic Class)
- Cyclooxygenase Inhibitors - [MoA] (Mechanism of Action)
- Decreased Platelet Aggregation - [PE] (Physiologic Effect)
- Decreased Prostaglandin Production - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Nonsteroidal Anti-inflammatory Drug - [EPC] (Established Pharmacologic Class)
- Phenothiazine - [EPC] (Established Pharmacologic Class)
- Phenothiazines - [CS]
- Plant Proteins - [CS]
- Platelet Aggregation Inhibitor - [EPC] (Established Pharmacologic Class)
- Seed Storage Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 64578 - Energetix Corporation
- 64578-0060 - Medi-chord
- 64578-0060-1 - 59.1 mL in 1 BOTTLE, DROPPER
- 64578-0060 - Medi-chord
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 64578-0060-1 identifies a specific commercial package of 59.1 ml in 1 bottle, dropper of Medi-chord, a human over the counter drug labeled by Energetix Corporation. This liquid is formulated for oral use and contains acetic acid; aspirin; corticotropin human; aluminum; atropa belladonna; benzene; chloramphenicol; chlorpromazine; cortisone acetate; estrone; sus scrofa adrenal gland; glycyrrhiza glabra; pork liver; potassium iodide; arctium lappa root; lycopodium clavatum spore; nitric acid; strychnos nux-vomica seed; kerosene; phenacetin; phosphoric acid; phytolacca americana root; lead; frangula purshiana bark; phenyl salicylate; sarsaparilla; thyroid, unspecified; trifolium pratense flower; elymus repens root as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Energetix Corporation on September 21, 2017. The current certification is valid through December 31, 2027.
How is this Energetix Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 64578006001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.